OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Neurotherapeutics is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	40
The latest developments in synthetic approaches to Duchenne muscular dystrophy	40
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	32
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis	31
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	27
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury	27
Current perspectives on the clinical management of cryptogenic stroke	26
The latest developments with internet-based psychological treatments for depression	26
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	26
An update on the treatment and management of cognitive dysfunction in patients with multiple sclerosis	25
Is it possible to prevent relapse in panic disorder?	22
Managing cognitive impairment in Parkinson’s disease: an update of the literature	22
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection	22
Where Art Thou O treatment for diabetic neuropathy: the sequel	21
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications	21
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options	20
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy	20
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics	20
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis	20
Advances in the management of bipolar disorder in children and adolescents: an update on the literature	19
Diagnosis of Lennox-Gastaut syndrome and strategies for early recognition	19
Current and emerging targeted therapies for spinal muscular atrophy	19
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	19
The management of neurofibromatosis type 1 (NF1) in children and adolescents	19
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	19

Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome	19
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	19